Correlation of Peripheral Blood T Cell Subtypes with Clinical Disability Levels in Patients with Multiple Sclerosis
-
By
-
Penju Liu
-
Wei Liu
-
Xiaoting Zhang
-
Peng Yuan
-
July 20, 2026
Clinical Scorecard: Correlation of Peripheral Blood T Cell Subtypes with Clinical Disability Levels in Patients with Multiple Sclerosis
At a Glance
| Category | Detail |
|---|
| Condition | Multiple Sclerosis |
| Key Mechanisms | Involvement of CD4+ and CD8+ T cells in immune-mediated pathology. |
| Target Population | Patients with Multiple Sclerosis |
| Care Setting | Tertiary neurology center |
Key Highlights
- Study involved 48 MS patients with mean EDSS score of 3.20 ± 1.50.
- CD4+/CD8+ ratio negatively correlated with EDSS scores (r = −0.345, p = 0.016).
- Progressive decline in CD4+/CD8+ ratio observed across disability severity groups.
- Exploratory analyses suggested DMT exposure may influence the CD4+/CD8+ ratio association with EDSS.
- Findings suggest potential for CD4+/CD8+ ratio as a peripheral immune indicator in MS.
Guideline-Based Recommendations
Diagnosis
- Confirmed MS diagnosis according to the 2017 McDonald criteria.
Management
- Consider disease-modifying therapies (DMT) based on clinical assessment.
Monitoring & Follow-up
- Utilize EDSS for standardized disability measurement.
Risks
- Recognize limitations of EDSS, including non-linearity and insensitivity to cognitive impairment.
Patient & Prescribing Data
Adults aged 18-65 with clinically stable MS.
DMT exposure may influence T cell subset ratios and disability correlation.
Clinical Best Practices
- Integrate peripheral blood T cell profiling with clinical disability assessments.
- Consider T cell subset distributions as potential biomarkers for disease monitoring.
Related Resources & Content
